Drugmaker Zydus has started supplying its three-dose COVID-19 vaccine ‘ZyCoV-D’ to the Government of India. The company also said in a statement that Zydus plans to make the vaccine available in the private market.
This vaccine from Ahmedabad-based Zydus Cadila was approved by the government on August 20 last year. Earlier, Zydus had tested the vaccine on 28 thousand volunteers. The specialty of this three-dose vaccine is that it does not use injections, but these vaccines are needle-free.
- Shocked cases of Coronavirus in India: 2.85 lakh new cases in last 24 hours
- Budget 2022: What is this special A to Z which can be heard in Sitharaman’s speech?
zycov-d vaccine news update 2022
There is something special in this corona vaccine, which is being said to be safe for children. This is the first plasmid DNA vaccine. Along with this, it will be applied with the help of pharma technology without the help of a needle, which will reduce the risk of side effects.
The third phase trial of Zydus Cadila’s corona vaccine ZyCoV-D has been done. It was attended by 28 thousand participants. This is now the biggest trial of any vaccine in India so far, its results have also been said to be satisfactory. During the second corona wave, its trial was conducted at 50 clinical sites in the country. It is said to be effective on the Delta variant as well.
Zydus Cadila’s zycov-d corona vaccine seems to be without a needle
The study found that Zydus Cadila’s ZyCoV-D corona vaccine is safe for children aged 12 to 18 years. It was found in the Pharmajet needleless technology study that Zydus Cadila’s ZyCoV-D corona vaccine is safe for children aged 12 to 18 years. By clicking the button on the PharmaJet needle-free applicator machine, the vaccine medicine reaches inside the body.
How effective is Zykov-D – zycov d efficacy
Zydus Cadila claims that the efficacy of this vaccine is 66.60 percent. This three-dose vaccine can be given at intervals of four weeks. It can be stored at 2-8 degrees temperature. It is a plasmid DNA vaccine. This is a needle-free vaccine, which can be given through a jet injector. The company has planned that it will produce 10-12 crore doses annually.
This is India’s second indigenous vaccine. Earlier, Bharat Biotech’s vaccine has been administered to the people. At present, five vaccines have been approved in the country. Zykov-D is the fifth vaccine after Covishield, Covaccine, Sputnik, Moderna.
No hassle of cloud storage
Another good thing with ZyCoV-D is that the temperature does not have to be kept too low to keep it, which means it has good thermostability. Due to this, there will be no hassle of the cold chain, etc., due to the lack of which till now the vaccine was being wasted. Making the vaccine on the plasmid DNA platform makes it easier. It requires minimal biosafety. Along with this, there is no problem with vector-related immunity.
What is Plasmid Based DNA Vaccine
Plasmid-based DNA vaccine works by enhancing antigen-specific immunity, which helps in fighting infection. The biggest advantage of having a Plasmid DNA vaccine is that it can be kept at a temperature of 2-8 degrees. India’s second corona vaccine is made in the Covaxin Bio-Safety Level 3 Lab. At the same time, the Zydus vaccine can be made in the Level 1 lab only.
- How to Cook Delicious and sizzling Mozzarella Sticks – step by step
- Vivo y75 5g launched: 50mp camera, 5000 mah battery know how much is the price?
- Up until election 2022: Spa released its list of 56 candidates
- Houthi attack UAE: There were also two Indians among the dead (UAE News 2022)
- Why is the Nord Stream 2 pipeline in the headlines amid the Russia-Ukraine crisis?